Radiopharm Theranostics set to home-in on expanded cancer suite
Radiopharm Theranostics (ASX: RAD) has received approval from the Australian Ethics Committee for the inclusion of additional tumour...
top of page
Search
James Pearson
Nov 18
Radiopharm Theranostics pancreatic cancer diagnostic test outperforms
Following publication of its findings in “Frontiers in Nuclear Medicine”, Radiopharm Theranostics (ASX: RAD) revealed a clinical study...
James Pearson
Oct 21
Radiopharm Theranostics locks in drug maker for US brain cancer trial
ASX-listed Radiopharm Theranostics (ASX: RAD) has teamed up with US-based BAMF Health to kick off phase 2b trials for its cancer...
James Pearson
Oct 16
Radiopharm Theranostics locks in cancer-fighting drug manufacturer
ASX-listed Radiopharm Theranostics (ASX: RAD) has joined forces with a renowned global radiopharmaceutical manufacturer to produce its...
James Pearson
Oct 3
Radiopharm Theranostics closes in on cancer-fighting drug approval
Radiopharm Theranostics (ASX: RAD) has moved closer to securing investigational new drug (IND) approval for a cancer-fighting...
Andrew Todd
Aug 26
Radiopharm Theranostics ups stake in US cancer-fighting venture
Radiopharm Theranostics (ASX: RAD) has boosted its stake in a United States-based joint venture (JV) with the University of Texas MD...
James Pearson
Aug 20
US medical guru jumps into Radiopharm Theranostics cancer fight
Radiopharm Theranostics (ASX: RAD) has secured the services of United States-based Dr Dimitris Voliotis as its new chief medical officer...
James Pearson
Aug 5
Radiopharm Theranostics banks US$2m in sales to American medical giant
Radiopharm Theranostics (ASX: RAD) has banked US$2 million (AU$3.1 million) from American medical giant Lantheus for the sale of two...
James Pearson
Jul 23
Radiopharm gets crucial nod for brain cancer imaging trial
Radiopharm Theranostics (ASX: RAD) has been given the nod of approval by the United States Food and Drug Authority to use its brain...
James Pearson
Jul 10
Radiopharm Theranostics unveils landmark human lung cancer trial
Radiopharm Theranostics (ASX: RAD) has kicked off the first phase of clinical trials testing its “RAD 204” treatment aimed at beating the...
Bart Bogacz
Jun 25
Radiopharm Theranostics soars on $70m funding for cancer treatment
Radiopharm Theranostics’ (ASX: RAD) stock rocketed up more than 35 per cent this morning after the cancer-fighting firm secured...
Michael Philipps
Jun 20
Radiopharm Theranostics set for $18 million boost in Lantheus deal
Radiopharm Theranostics (ASX: RAD) looks set to fill its coffers with a healthy $18 million following a strategic equity investment and...
Doug Bright
Mar 18
Radiopharm eyes kidney protection in cancer radiotherapy
The potential for one of Radiopharm Theranostics’ (ASX: RAD) treatments to fight cancer while protecting a patient’s kidneys from...
Doug Bright
Mar 1
Terbium emerging as cancer-fighting key for Radiopharm
Radiopharm Theranostics says a new six-patient study shows its terbium-based treatment has superior potential to tackle prostate cancer...
Michael Philipps
Feb 29
First pancreatic cancer patient dosed in Radiopharm study
Radiopharm Theranostics says it has dosed its first pancreatic cancer patient in the initial phase of a study aimed at providing doctors...
Doug Bright
Feb 6
Radiopharm strikes new blow in fighting aggressive tumours
An immune system protein being developed by Radiopharm Theranostics has for the first time been shown to have the potential to detect and...
Doug Bright
Dec 27, 2023
Radiopharm expands lung cancer trials sites to Perth
Radiopharm Theranostics is poised to open a second site for conducting human trials of its RAD 204 treatment for advanced non-small cell...
Doug Bright
Dec 22, 2023
Radiopharm set for “game-changing” lung cancer trial
Radiopharm Theranostics has stepped closer to kicking off what it says could be a “game-changing” trial for patients with non-small cell...
Doug Bright
Nov 21, 2023
Tax rebate to help Radiopharm diagnose, treat cancers
A research and development (R&D) tax rebate of nearly $5 million from the Australian Government will boost Radiopharm Theranostics’...
Doug Bright
Oct 17, 2023
Radiopharm trials to lift pancreatic cancer hopes
Pancreatic cancer patients have been delivered fresh hope following the United States Food and Drug Administration’s decision to clear...
bottom of page